






HUMAN PAPILLOMAVIRUS IN ARGENTINA: AN IN-
DEPTH STUDY OF THE CAUSE OF THE FREQUENCY OF 
HPV IN WOMEN IN BUENOS AIRES 
 
TO ANALYZE THE REASONS WHY HPV IS SO 
PREVALENT IN WOMEN IN BUENOS AIRES AND TO 
DETERMINE WHY THE SPREAD OF HPV PERSISTS 






















Presented to the Department of Biology  
and the Robert D. Clark Honors College  
in partial fulfillment of the requirements for the degree of  
Bachelor of Science 
 
June 2016
An Abstract of the Thesis of 
Foley Galvin for the degree of Bachelor of Science 
in the Department of General Science to be taken June 2016 
Title: Human Papillomavirus in Argentina: An In-Depth Study of the Cause of the 
Frequency ofHPV in Women in Buenos Aires 
Human Papillomavirus in Argentina: An in-depth study of the cause of the 
widespread incidence ofHPV among the women in Buenos Aires to determine why 
HPV is so prevalent in this population despite many available prevention methods. 
Contextual Information: 
The Human Papillomavirus is the most common sexually transmitted infection 
(STI) in the world, and can lead to serieus health problems such as cancer ("Human 
Papillomavirus"). However, it is also easily preventable. A series of vaccines as well 
as condoms can prevent the spread of this virus ("Human 
Papillomavirus"). Argentina's public health care system offers free vaccinations and 
contraceptives that can prevent HPV infection. Despite its preventability, HPV 
infection is still common. There are over 100 different forms ofHPV (Ministerio de 
Salud), and almost every sexually active person will contract some form ofHPV in his 
or her lifetime ("Human Papillomavirus"). Like other diseases, such as the common 
cold or flu. there is no treatment for HPV, but the body's immune system can fight off 
the virus. However. unlike the cold or flu, which last only a matter of days, HPV 
infection can last years, providing ample time for an infected person to pass the disease 
on to a sexual partner. In addition, the symptoms of HPV may not appear for months or 







Human”).  If a person’s immune system is weakened, the HPV can cause cells to 
become cancerous or lead to genital warts (“Virus del Papiloma Human”).  A study 
conducted in Argentina found that 51.6% of women surveyed tested positive for 
HPV.  Of that total, 7.3% tested positive for more than one form of HPV, and more than 
a quarter of them were found to have a form of HPV linked to cervical cancer (“HPV 
vaccine in Argentina”).   
This investigation seeks to determine why HPV remains a problem in Buenos 
Aires despite its preventability.              
 
Methodology: 
This study was uses qualitative and quantitative information from primary and 
secondary sources.  Secondary sources made up the majority of the quantitative 
information.  The Ministry of Health of Buenos Aires and the Instituto National del 
Cancer provided statistics on percentages of women with varying forms of HPV and 
cervical cancer.  Qualitative information was obtained from interviews of medical 
professionals and parents with daughters.  Both the qualitative and quantitative 
information was analyzed to identify reasons for the high rates of HPV in Buenos 
Aires.                 
 
Results:  
After conducting interviews with medical professionals and parents of girls of 
vaccination age, and analyzing statistics of HPV patients, I concluded that the 
prevalence of HPV in Argentina can be attributed primarily to the public’s lack of 
knowledge regarding HPV, and its vaccine.  Misinformation and a general lack of 
knowledge have made some persons wary of the vaccine.  Factors such as low income 
level, limited access to the public healthcare system, inconvenience, and parents’ 
personal bias against the vaccine seemed to play only small roles in deterring people 
from the vaccine and using other forms of prevention.  Despite programs designed to 
educate people about HPV and to promote the HPV vaccine, many people still seem 
unaware of the severity of the infection and the availability and effectiveness of the 
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There are over 100 types of the Human Papillomavirus—some relatively 
harmless and some potentially deadly (“Virus del Papiloma Human”).  These different 
forms of the virus can cause numerous problems, from genital warts to cervical 
cancer.  Around 40 types of HPV can affect the genital area of both males and females 
(“Human Papillomavirus”).  While the body’s immune system can generally eliminate 
the virus after a few years, symptoms may not be apparent for years or may never 
surface.  Thus, people carrying the disease may be unaware that they are 
contagious.  Infected people then unknowingly transmit the disease to their sexual 
partners, who may in turn display more severe symptoms.    
HPV is very common.  Almost every sexually active person will contract some 
form of HPV in his or her lifetime (“Human Papillomavirus”).   Frequently, men will 
contract strains of HPV without presenting symptoms.  They may then pass the disease 
on to a sexual partner.  Women, in contrast, are more likely to present with symptoms 
and be affected by the disease.  Both men and women are capable of naturally 
combating HPV; however, if their immune system has difficulties combating HPV, the 
virus can have more severe effects on the body.    
HPV can cause genital warts or several types of cancer.  However, the types of 
HPV that cause cervical cancer do not cause genital warts (“Human 
Papillomavirus”).  In rare cases a mother with genital warts may transmit a respiratory 
illness during birth known as respiratory papillomatosis (RRP), in which the baby may 
develop warts in its throat and have trouble breathing (“Human 






years.  HPV can damage cells throughout the body that may become cancerous even 
after the HPV has been eradicated (“Virus del Papiloma Human”). 
According to the National Cancer Institute:  
Once HPV enters an epithelial cell, the virus begins to make 
the proteins it encodes. Two of the proteins made by high-risk HPVs (E6 
and E7) interfere with cell functions that normally prevent excessive 
growth, helping the cell to grow in an uncontrolled manner and to avoid 
cell death. Many times these infected cells are recognized by the immune 
system and eliminated. Sometimes, however, these infected cells are not 
destroyed, and a persistent infection results. As the persistently infected 
cells continue to grow, they may develop mutations in cellular genes that 
promote even more abnormal cell growth, leading to the formation of an 
area of precancerous cells and, ultimately, a cancerous tumor. 
 (“HPV and Cancer”) 
 
Cervical cancer is the second most common type of cancer among women in the 
world.  In Argentina, cervical cancer ranks as the third most common type of cancer and 
the second most common for women.  But, unlike other forms of cancer, most cervical 
cancer can be prevented with a vaccine.  In 2013, 4,956 new cases of cervical cancer 
were diagnosed in Argentina.  99% of cervical cancer cases are caused by a form of 
HPV. Approximately 70% of cases are due to high-risk forms of HPV such as types 
HPV16 or HPV18 while 30% of cases are caused by lower risk forms (“Human 
Papillomavirus (HPV) Vaccines").  Lower-risk forms can still be cancer causing but 
cervical cancer is more likely to develop form the high-risk forms. While some HPV 
symptoms like genital warts generally dissipate over time, other forms of HPV can have 
other severe repercussions.  Cancerous forms of HPV can affect can permanently affect 






fight off the disease, their damaged cells can become cancerous (“Human 
Papillomavirus”).     
In a study conducted in Buenos Aires in 2007, tissue samples from 77 patients 
were assayed for HPV at the Stomatology Department of the Faculty of Dentistry at the 
University of Buenos Aires.  Of these samples, 55.8% of the samples tested positive for 
a form of HPV.  Among the 55.8%, 60% of the strains of HPV had the potential to be 
cancer causing.  The most frequent types of HPV present were forms 6, 11 and 
16.  While strain 6 is relatively harmless, strain 16 has been identified as cancer causing 
(“HPV vaccine in Argentina”).  On average 20.1% of women in Argentina have a form 
of HPV that could lead to cervical cancer (“Human Papillomavirus and Related 
Cancers”).     
The HPV vaccine was first approved in Argentina in 2006.  There are currently 
two different forms of the vaccine—Cervarix and Gardasil.  While both are effective in 
preventing cancer, only Gardasil additionally prevents genital warts (“Human 
Papillomavirus”).  According to the World Health Organization, in Argentina the HPV 
vaccine can first be administered to girls of age nine years and older.  However, the 
vaccine is free for only girls who are 11-year-old girls (“HPV vaccine in 
Argentina”).  The vaccine can cost around 400 pesos (around 40 US dollars) for 
children and young adults over twelve (Pianko, 2014).  In 2008, a non-governmental 
organization started a campaign to promote the vaccine.  However, due to poor program 
implementation and criticism about the promotion of the vaccine, the campaign left 
many Argentines with a bad image of the vaccine (Arrossi, 2012).  At a press 






explained the importance of the HPV vaccine.  She also spoke about Eva Peron, a 
beloved heroine in Argentine history who died from cervical cancer that was likely 
caused by HPV (Buenos Aires Herald).  Through the President’s efforts the Ministry of 
Health of Argentina added the HPV vaccine to the National Immunization Program in 
October 2011 meaning that the vaccine is now encouraged for girls ages 9-12 but is still 
not mandatory (“Human Papillomavirus and Related Cancers”).  
There are two tests that can detect HPV or cancerous lesions.  One is called the 
HPV test. Women 30 and older can have this simple test done.  However this test is 
available in only a few provinces in Argentina and is not yet available in Buenos Aires 
(Paolino, 2014).  If the HPV test is unavailable, for women younger than 30 or if the 
results are positive for HPV, an additional test called a Papanicolaou test (also known as 
a Pap smear) can be performed. If woman’s Pap smear is positive—indicating the 
presence of abnormal cells most likely resulting from HPV, the woman will repeat the 
test in a year wherein most cases this will have been ample time for the woman’s body 
to rid the virus. While the results of a Pap smear cannot detect specifically for HPV, the 
presence of abnormal cells and the severity of the infection can be determined. The 
results of a Pap are categorized according to the Bethesda System that reports a 
woman’s Pap on a scale depending on the severity of abnormality ranging from 
relatively harmless “atypical squamous cells of undetermined significance” to 
“adenocarcinoma” cancerous cells (“Pap and HPV Testing."). Pap smears are free to all 
women in Buenos Aires (“Las Dos Necesitan un PAP”).                      







This thesis aims to explore the causes of the high prevalence of HPV in 
Argentina—specifically in the city of Buenos Aires.  Argentina’s universal health care 
system provides free HPV vaccination to 11-year-old girls, as well as free HPV testing 
should aid in the prevention of HPV and cervical cancer. Therefore, I am going to 
investigate why HPV infection remains such a problem in Buenos Aires despite 
preventability.  
There are several explanations for the high incidence of HPV.  First, the cost of 
the HPV vaccines for persons over the age of 12 years could deter some from receiving 
them.  
For the free vaccines, it may be difficult for a patient to schedule an appointment 
to receive them.  The vaccines also require three separate doses several months 
apart.  While the vaccines are not time sensitive, they are fully effective only if all three 
doses are administered (“Human Papillomavirus”).  Therefore, it is crucial that the 
patient is able to receive all three vaccinations, which may be difficult given the 
crowded public clinics in Argentina.  Interviews conducted with public health 
professionals can help to give a better understanding of if cost or scheduling issues are 
key factors preventing people from receiving the vaccine.  
Additionally, a comparison of vaccination rates for HPV and other diseases 
between Argentina and other countries could shed light on whether or not Argentina’s 
vaccination rates are a general problem or are specific to HPV.            
It is possible that many people are uneducated about the simplicity of preventing 






severity HPV.  Unlike the some infections that lasts only a matter of days or weeks, 
HPV can last for years—giving the infected person ample time to infect other people 
with the virus.  Determining the population’s level of understanding about HPV 
incidence and risks and the options available for preventing its spread may reveal 
whether a lack of HPV education is a leading cause in the spread of the infection. This 
information can be gathered through interviews, population-based surveys and 
previously conducted studies.   
While perhaps not as pronounced as in the United States, anti-vaccination 
movements may play a part in the negative perception of the HPV vaccines. Anti-
vaccination groups are motivated by various factors such as religion or false health risks 
associated with the vaccine. An in-depth look at the motivation behind these groups and 
at their impact on Argentine society could indicate whether anti-vaccination groups 
deter the public from receiving the HPV vaccine.      
The recommended age for a person to become vaccinated against HPV is before 
he or she is sexually active (“HPV vaccine in Argentina”).  Additionally, between 9 and 
13 years of age, the body will produce the highest immune response making the age the 
optimal time for a person to be vaccinated ("HPV Vaccine Is Recommended for Boys"). 
But for many parents this is controversial.  Often parents refuse to admit that their 
children may become sexually active at a young age and thus may not permit their 
children to become vaccinated in time. This can be detrimental to the children’s health 
if they contract HPV after becoming sexually active but before being 
vaccinated.  Although the vaccine should be administered at a young age, it is 






reduce their risk of HPV, genital warts and cancer ("HPV Vaccine Is Recommended for 
Boys").  Parental opinions gained from interviews and previous studies will aid the 
investigation because they can provide insight into whether parents’ choices influence 
the high rates of HPV.      
Dating and sexual customs, such as an increase in promiscuity, in Argentina 
may affect how quickly HPV spreads from one person to another.  Sexual habits can 
greatly affect the transmission of a disease, and negative views of HPV prevention 
methods could lead to a faster spread of HPV.  In addition, the age that people become 
sexually active can affect how quickly the disease spreads.  The earlier a person 
becomes sexually active, the less likely they have been vaccinated for HPV or been 
exposed to sex education. Doctor’s observations recorded via interviews of patterns of 
sexual relations among their patients will help to determine the cause behind the high 
rates of HPV. Additionally, studies regarding the sexual activity of adolescents in 
Argentina could provide insight into if teen promiscuity could be one reason the 
incidence of HPV is so high.    
Both qualitative and quantitative information are important for this 
investigation. The statistics from secondary sources give factual support to the causes 
behind the prevalence of HPV. The Center for Disease Control of the United States, The 
Ministry of Health of Buenos Aires and of Argentina, The World Health Organization, 
The National Cancer Institute of Argentina and published studies conducted by the 
Argentine government provide data to support this investigation. Interviews with 
medical professionals provide a better understanding of the personal choices that affect 






people have about HPV, the vaccine, and the resulting risks of cervical cancer. Doctors 
providing their perspective on their patients’ views of HPV, how the public healthcare 
system works to prevent HPV and cervical cancer, and why they believe HPV remains 







Many limitations to this study were recognized during this investigation. The 
investigation started with the intention of asking women about their personal habits 
regarding HPV prevention. But, it became apparent that because HPV relates to a 
person’s sexual health, interviewing women about their sexual history would be 
difficult. Therefore, all interviews conducted were with medical professionals and 
adults with daughters. 
In addition, because HPV infection often does not present with any symptoms, 
the majority of people living with HPV are unaware they have it. This made it more 
difficult to find sufficient information on HPV-infected populations. This investigation 
had to be expanded to consider women who suffer from cervical cancer that most likely 







Evidential Support  
Quantitative Analysis 
Because HPV often does not present with symptoms, the presence of cervical 
cancer in women is a better indicator of the prevalence of HPV as the majority of 
cervical cancer cases result from HPV infection (“Human Papillomavirus (HPV) 
Vaccines"). According to the World Health Organization, the cervical cancer mortality 
rate in Argentina is almost four times higher than that in the United States (“Worldwide 
Cancer mortality statistics”); in the province of Buenos Aires the mortality rate of 
cervical cancer is above the Argentine national average (Arrossi and Paolino, 







Figure I: Percentage of cervical cancer related deaths of total uterine cancer related 
deaths by jurisdiction (2003-2005) 
Source: (Arrossi, 2008) 
Since the introduction of the HPV vaccine in 2006 in both Argentina and the 
United States, Argentina still trails behind the US in its overall vaccination rate. In the 
US on average, 60% of girls have received all three doses although this number varies 
from state to state ("HPV Vaccine Coverage Maps”). Compareitvely in Argentina, 
while the first dose is high at 87.9%, only 52.2% of girls have received all three doses  
(Patel et al, 2016).   
Cervical cancer in general is equally prevalent in women regardless of income, 
personal beliefs or marital status. Table I shows various characteristics among women 
with cervical cancer. The table shows that the majority of women with cervical cancer 
live above the poverty line.  Data collected from 2002-2004 found that 45% of women 
with cervical cancer live below the poverty. However in 2003, another study found that 
























51.7 of Argentinians were living below the poverty line ("The World Factbook: 
Argentina").  This indicates that poor socioeconomic status does not play a significant 
role in a women’s likelihood to contract HPV. The data suggest that women living 
above the poverty level are just as likely to develop cervical cancer, implying that 
factors like the cost of the vaccine or healthcare access in public clinics may only be a 
small factor in high cervical cancer rates.  
A study conducted in 2012 in Argentina (Arrossi et al., 2012) concluded that 
“no significant differences in socio-demographic characteristics were found among 
women who would or would not get vaccinated.” Once informed of the vaccine and its 
benefits, the 226 women participating in the study were asked if they were in agreement 
with the vaccine. 75% of the women in the study answered “surely/probably yes”. 
Additionally, the most frequent reason women cited for their lack of vaccination was 
that their doctor had not recommended it. Thus, doctor recommendations could increase 
the vaccination rate. The study also determined that the potential acceptability of the 
vaccine is high given that there is acceptance among the professional community and 
vaccine is affordable but somehow critical information about HPV and cervical cancer 





Average age 51 






Never attended school 6.7 
Attended primary school 69.2 


















Employed without social 
protection  
37.5 







Health coverage (private or through employment) 
No 75.8 
Yes 24.2 
Table I. Argentina. Socio-demographic characteristics of cervical cancer patients 
(2002-2004) 
Source: (Arrossi, 2008) 
In addition, the majority of women with cervical cancer are married women—
suggesting that it is not only women with multiple sexual partners who are at high risk 
for contracting HPV, but monogamous women as well. This could also be attributed to 
the fact that HPV can lie dormant within the body even after a woman is married. 
Cervical cancer also can also take year to develop causing a high number of cervical 
cancer cases in older women.  Additionally, this table shows that a high incidence rate 
from cervical cancer correlates with a lack of education: 69.2% of women with cervical 
cancer have completed only a primary level of education (Arrossi and Paolino, 2008) 
while 90.6% of the general female population in Argentina has completed a primary 
level or higher ("Estadísticas", 2015).  For many years in Argentina cervical cancer has 
been thought of as a disease that affects only the poor. In one analysis of cervical cancer 
in Argentina, Doctor Silvina Arrossi argues that is not only poor women who are 
affected by cervical cancer, Additionally, many women wait until it is too late for 
treatment before their cancer is diagnosed. She states the cervical cancer generates 






working informally and therefore do not have social protections like health care 
(Arrossi and Paolino, 2008) 
Since the HPV vaccine was first introduced in 2006, cervical cancer rates have 
remained rather steady (Zamberlin, 2011) (See Figure II). In theory, the introduction of 
the HPV vaccine should have led to a decline in cervical cancer over time, yet cervical 
cancer rates remain greatly unchanged. However, it is likely that the effect of girls who 
were vaccinated for HPV will not be seen as a decrease in cervical cancer for many 





Figure II: Rate of cervical cancer mortality by year standardized for 100,000 women 
Source: (Arrossi, 2008)     
Vaccination efforts in Argentina in general appear successful. Vaccination 
coverage for other diseases ranges from 91 to 100 percent (“Immunization, Measles”).  
Argentina vaccinated around 95% of children against the measles virus in 2011, while 






































in recent years (“Immunization, Measles”). While these values may not be statistically 
significant, it appears that the low rate of HPV vaccination in Argentina is an exception 
to the otherwise overall high vaccination rate in this country.      
While not as forceful as in the United States, anti-vaccination movements, such 
as the “Libre Vacunacion” movement, contribute to vaccination non-compliance in 
populations.  These organizations have as their mission granting parents the freedom to 
choose whether or not they want to have their children vaccinated, as many vaccinations 
are mandatory in Argentina. Libre Vacunacion, which translates to Free Vaccination, 
cites the many states in the U.S. in which parents have the right to choose to vaccinate 
their children, and the group requests the same freedom in Argentina. They have started 
a petition to abolish the mandatory vaccination laws. They also warn that 40% of 
doctors do not inform their patients of potential risks associated with vaccines (“Libre 
Vacunacion”). While this statistic may be true, many of the associated risks are 
negligible, or the benefits of that vaccine far outweigh potential side effects. An article 
published in La Nacion, one of Argentina’s leading newspapers, explains that despite 
some risks, vaccinations, along with clean drinking water, has decreased the mortality 
rate the most worldwide (Dema, 2014). La Nacion also details how some people in 
Argentina are misinformed about the physiology of immunity. Some individuals believe 
that diseases like HPV can be beneficial by ridding the body of other diseases, but this 
is medically inaccurate (Dema, 2014).    
An article published in 2014, entitled “The Risk of Misinforming when Talking 
about Vaccination” also shed light on the circulation of misinformation regarding 






rumors that mandatory vaccinations are a collaboration between pharmaceutical 
companies and the government, and that vaccines can cause serious health risks, such as 
autism. A paper published in 1998 showing a link between vaccines and autism (Rao, 
2011) was retracted in 2010 because information in the study had been falsified. 
According to an article entitled “Doctors in Argentina Sound the Alert on Vaccine 
Skeptics” by Marcela Valente, the retraction of the article did not stop public 
uncertainty surrounding the safety of vaccination (Valente, 2013).  
In response to an flawed article entitled “Vaccines: yes or no?” (Etchebarne, 
2014) the Argentine Scientific Journalism Network (“Vacunas: Una Desinformación 
Peligrosa”) issued a press release warning people about serious misinformation in 
important health matters like vaccines. The release also countered the notion believed 
by many people that some diseases have been eradicated, and the corresponding 
vaccines are thus no longer necessary. The release points out that in countries in which 
vaccination is not mandatory, preventable diseases like measles and whooping cough 
are on the rise (“Vacunas: Una Desinformación Peligrosa”).     
Another article published in La Nacion, “Who Are the Parents Who Don’t 
Vaccinate Their Children and What are They Thinking?” (Dema, 2014) describes how 
parents believe vaccines are filled with harmful chemicals and vaccines can prevent 
children from contracting conditions that are actually good for their health. The official 
response to this article from the Ministry of Health of Argentina was a reminder that, 
according to law 22909, all mandatory vaccines are free and are not only beneficial to 
the individual being vaccinated, but to society as a whole. Having the general public 






elderly. Despite these anti-vaccination movements, the secretary of the Argentine 
Pediatric Society’s Committee on Infectious Diseases, Carlotta Russ, commented on 
these movements stating that, “Fortunately, in Argentina, the anti-vaccine movement is 
not strong” (Valenta, 2013). While there is some backlash against the HPV vaccination, 
these movements do not seem to play a significant role in low vaccination rates and the 
high incidence of HPV and cervical cancer (Doctors in Argentina).    
A journal article published in 2016 (Patel et al, 2016) sought to measure the 
success of the implementation of the HPV vaccine. The study concluded that overall 
implementation of the vaccine was successful, citing nearly 100% coverage rates for the 
first dose of the vaccine for girls born in 2000 or 2001 in some areas. However, this 
number varied greatly around the country and drastically dropped for each subsequent 
dose. Because the vaccine is effective only if an individual receives all three doses, the 
third dose is the most important and the best indicator of vaccination coverage. The 
article concluded “the Argentinian government has been able to achieve high average 
rates of coverage by the HPV vaccine since including the vaccine in its national 
immunization schedule. However, further program effort is needed to reduce the 
variance in HPV coverage rates across provinces and improve HPV coverage rates 
across all three vaccination doses” (Patel et al, 2016).  
In 2012, an extensive survey (Chaparro et al, 2016) was conducted to determine 
the acceptance rate of the HPV vaccine of parents of girls eligible to be vaccinated, their 
knowledge of HPV, and how religion may affect their willingness to vaccinate their 
daughters. The study found that the overall acceptance rate (those who supported HPV 






that they had heard of HPV but only 52.7% knew there was a vaccine that could prevent 
infection of harmful strains. Religion was practiced by 86.8% of the parents surveyed. 
The study concluded that despite a large percentage of parents who practice religion, the 
parents did not cite religion or their socioeconomic status and the cost of the vaccine as 
the cause of the low rate of acceptance. The majority of parents seemed to be in 
opposition to the vaccine for unknown reasons. This study provides data that suggests 
religion is not a primary factor in a parent’s choice to vaccinate their daughter 
(Chaparro et al, 2016). 
A comparison of the United States and Argentina reveals that sexual activity of 
teenagers in the two countries is comparable. A survey conducted in 2012 by Dr. 
Jonatan Konfino (Konfino, 2012) interviewed 13-15 year old students at several schools 
in Argentina. The survey showed that 36.9% of the students interviewed had sexual 
intercourse (Konfino, 2012)(Table II). This number varied between genders—among 
boys surveyed 43.5% had had sexual intercourse while only 30.7% of girls had 
(Konfino, 2012). In the United States, it was found that 46.8% of high school students 
had sexual intercourse. This number is slightly lower for 15 years olds at 41.4% 
(Konfino, 2012)(Table III.). This indicates that because the number of teenagers in the 
United States is comparable to the number of teenagers in Argentina that the high rates 
of HPV in Argentina is most likely not caused by promiscuity of teenagers who have 
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Among students who ever had sexual 
intercourse, the percentage who ad 
sexual intercourse for the first time 








Table II. Argentina. 2012 Fact Sheet. Results for students aged 13-15 years 
Source: ((Konfino, 2012)  
 
 
Table III. United States. Percentage of high school students who ever had sexual 
intercourse and who had sexual intercourse for the first time before age 13 years, by 
sex, race/ethnicity, and grade — United States, Youth Risk Behavior Survey, 2013 









Two gynecologists, Mónica Pianko and Moira Perkins, were interviewed at the 
Centro de Salud Y Acción Communitaria 34 (CeSAC 34) in Buenos Aires. Doctors 
were asked if they felt that patients had adequate access for appointments to receive the 
vaccine, and if the CeSACs are adequately supplied with the vaccine and with other 
methods of prevention, such as condoms. Both doctors agreed that appointments are 
readily available for girls to be vaccinated and that clinics are well supplied with the 
HPV vaccines and condoms. 
The two gynecologists were questioned about what they believed to be the 
biggest factor in the prevalence of HPV. They both agreed that misinformation and a 
lack of education contributed to the high rates of HPV and cervical cancer. There are 
only two programs currently in place to promote awareness about HPV and cervical 
cancer. One program is the National Vaccination Program (Paolino, Melisa interview). 
The other is the National Program for the Prevention of Cervical Cancer (Paolino, 
2014). This program aims to 1) treat and study women with cervical cancer, 2) educate 
the community, 3) supervise how information is given to the public, and 4) monitor the 
directors in charge of cancer prevention to attempt to help the program run smoothly 
(Paolino, 2014). Despite these guidelines put forth by the program, information about 
HPV and cervical cancer is not reaching all in the target audience.  
Melisa Paolino, who works at the National Cancer Institute of Argentina 
conducting research on cervical cancer, expressed concern about the level of women’s 
knowledge of HPV and its links to cervical cancer. In her opinion, most women were 






were questioned about cervical cancer, however, fewer women were familiar with this 
disease. Fewer still were aware of HPV and the vaccine, and the relationship between 
HPV and cervical cancer (Paolino, 2014). 
In the three interviews conducted with people in various healthcare fields, all 
agreed they saw few economic or social factors that affected a woman’s likeliness to 
contract HPV. The gynecologists saw no relationship between social-economic level 
and an increased risk of HPV (Pianko, Monica). The only social factor observed that 
could increase a woman’s likelihood to contract HPV was whether she chose to have 
unprotected sex with multiple partners (Perkins, 2014). 
I conducted an informal survey with parents whose daughters had the potential 
to be vaccinated. This revealed that most were familiar with HPV, but fewer were 
familiar with the vaccine.  Of the parents who were familiar with HPV, all of them 
agreed that they wanted their daughters to be vaccinated and had no ethical concerns 
about the vaccine. Despite the fact that HPV vaccination is now part of the national 
vaccination campaign, many parents are still unfamiliar with HPV-related diseases. 
Compounding the problem is the fact that the vaccine is free for only eleven-year-old 
girls. This is a relatively small window of time considering that the girls must receive 
all three does in this time frame for full immunity.     
A study conducted by the Ministry of Health of Argentina created 14 focus 
groups composed of 79 women between the ages of 25 and 64 and surveyed them about 
their perceptions of cervical cancer and Pap smears (Zamberlin, 2011). Some women 
described how they go to the doctor only if she feels sick. They did not see the point in 






believed that if one was married, or had only one sexual partner, a Pap smear was no 
longer necessary (Zamberlin, 2011). Other women believed that Pap smears were 
shameful and could be very painful (Zamberlin, 2011). This misinformation further 
inhibits women from protecting themselves and others against the spread of HPV. The 
study concluded that the general knowledge of women about the causes of cervical 
cancer was “vague and confused” and the majority of the women surveyed were 







What proved to be the biggest obstacle for Argentine females getting vaccinated 
was the lack of education about HPV among women and parents of vaccine-eligible 
daughters. As shown in Table II, a lack of education corresponds with a woman's 
likelihood of developing cervical cancer, which was most likely a result of the woman 
having HPV. As stated in the interviews with gynecologists, the government of 
Argentina adequately supplies the public clinics with condoms and vaccines that can 
prevent the transmission of HPV. Therefore, it is not the public health system of 
Argentina that is responsible for the rapid transmission of this disease. The medical 
professionals also agreed that there were no obvious economic patterns that would 
explain higher HPV rates in Argentina compared to those of the United States.   
When parents were asked if they were in agreement with the vaccine, those who 
were familiar with the vaccine unanimously said that they favored vaccination. Parents’ 
personal bias is not a large factor in the high prevalence of HPV, as all seemed willing 
to vaccinate their daughters. However, a concerning number of parents interviewed had 
not heard of the vaccine. Many people in Buenos Aires remain uneducated about HPV, 
which supports the notion that this lack of information could be the biggest contributing 










In conclusion, it was the opinion of all medical professionals interviewed 
supported by population surveys that misinformation and a lack of understanding of 
HPV accounted for the prevalence of HPV in Buenos Aires. This conclusion is 
supported by interviews conducted with parents of vaccine-eligible girls. Previous 
studies suggest that religion, socioeconomic status, and anti-vaccination movements do 







One important step that can be taken towards HPV prevention is to introduce the 
HPV test to other provinces. Considering that the majority of the population of 
Argentina resides in the city of Buenos Aires, the HPV test could be a very useful tool 
to prevent the spread of HPV in this large metropolitan area. If women in Buenos Aires 
were able to receive this test would and learn that they had contracted the virus, they 
could take precautions to ensure they do not infect others. 
In 2006 the HPV vaccine was approved by the Food and Drug Administration of 
the United States (Zamberlin, 2011). The US is taking steps to vaccinate as many 
people as possible, including boys. Since males are often asymptomatic for HPV 
infection, this preventative step will help reduce the number of cervical cancer cases in 
women. In addition, the vaccine is mandatory in 21 states in order to attend public 
school (Zamberlin, 2011). In the future, the government of Argentina could work to 
promote the vaccine for males as well as make the vaccine mandatory for school-age 








Informed Consent  
Mi nombre es Foley Galvin y soy estudiante de biología en la Universidad de 
Oregon en los Estados Unidos. En 2014, la entrevisté mientras estaba haciendo un 
intercambio en Buenos Aires en donde le pregunté sobre su experiencia en 
relación con la prevención de la propagación del VPH. Actualmente continúo 
desarrollando mi investigación sobre este tema, y me preguntaba si sería posible 
retomar la línea de nuestra entrevista y expandir mis preguntas sobre el VPH y sus 
métodos de prevención. Estaría extremadamente agradecida por su ayuda y 
colaboración, con  miras a expandir y solidificar mi proyecto. En tanto profesional 
de la salud, su opinión ofrece una perspectiva invaluable para mi trabajo y esta 
entrevista no conllevará ningún riesgo para usted. El propósito de solicitarle una 
nueva entrevista obedece a la necesidad de entender más cabalmente las razones 
por las cuales el VPH parece ser un problema prevalente en la población de Buenos 
Aires, aun a pesar de la variedad en los métodos de prevención.  Entenderé si usted 
no se sintiera cómodo/a respondiendo a alguna o a todas las preguntas del 
cuestionario, o si hubiera decidido no permitirme usar la información que he 
obtenido durante nuestra entrevista del 2014. De más está decir, que puedo omitir 
cualquier información que usted no desee que forme parte de mi estudio, incluido 
su nombre si prefiere resguardar su identidad como confidencial. En cualquier 
caso, por favor, no dude en hacérmelo saber por vía de correo electrónico, 
especialmente si usted no deseara participar de esta nueva entrevista. Si acepta 
participar, por favor, complete con respuestas breves las preguntas que se 
encuentran a continuación de este documento. Sus respuestas serán transmitidas 
por vía de correo electrónico y serán archivadas en una carpeta protegida con 
contraseña especial. Como parte del proceso de transparencia de la Universidad, 
debo informarle oficialmente que en la mayoría de las investigaciones, existe un 
pequeño riesgo de que su información llegue a manos de quien no debería acceder 
a ella.  Adicionalmente, debo informarle que el correo electrónico no es 
considerado el medio más seguro de comunicación. Finalmente, agradecería si 
usted pudiera darme permiso para utilizar en mi estudio la información que ha 
compartido conmigo en ocasión de nuestra entrevista del 2014.  Desde ya, estoy 
muy agradecida por su disponibilidad para hablar conmigo y por compartir su 
experiencia sobre este tema. Todas nuestras interacciones serán archivadas en una 
computadora bajo contraseña cifrada.  Cuando concluya mi estudio, podré 
compartir mis resultados con usted, si así lo desea, pero no percibirá beneficios 
adicionales.   Por favor, guarde una copia de su consentimiento para su archivo 
personal. Si completa y devuelve las respuestas a las preguntas que se hallan a 
continuación, usted estará dando su consentimiento para participar en esta 
investigación. . Si tiene alguna pregunta sobre sus derechos como sujeto de 
investigación, puede comunicarse con: Research Compliance Services, Universidad 







Le reitero mi profundo agradecimiento por su ayuda para completar mi 
investigación.  










1.     ¿Cuáles son los métodos más prevalentes de prevención en la zona donde 
usted trabaja?  
 
2.     ¿Cuál considera que es la población más afectada por el VPH en esta zona? 
¿Quiénes la conforman (por ejemplo, mujeres, edad, con hijos, solteras, en pareja, 
con otros problemas de salud, etc.)?  
 
3.     En su trabajo, ¿ha observado algún factor específico (como hábitos sexuales, 
etc.) que contribuyan a la contracción de VPH?  
 
4.     ¿Qué tipo de personal médico trata más frecuentemente con personas que 
hayan contraído el VPH? 
 
5.     En su opinión, ¿la gente de la zona donde trabaja tiene acceso a información 
sobre el VPH? 
 
6.     ¿Dónde obtienen esa información?  
 
7.     En su opinión, ¿la gente de la zona donde trabaja conoce métodos de 
prevención de VPH?  
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